Severe familial ALS with a novel exon 4 mutation (L106F) in the SOD1 gene

Stefania Battistini, Claudia Ricci, Enrico Maria Lotti, Michele Benigni, Stella Gagliardi, Riccardo Zucco, Massimo Bondavalli, Norina Marcello, Mauro Ceroni, Cristina Cereda

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease associated with a positive familial history in 5-10% of ALS cases. Mutations in the superoxide dismutase-1 (SOD1) gene have been found in 12%-23% of patients diagnosed with familial ALS. Here we report a novel mutation in exon 4 of SOD1 gene in a 55-year-old ALS patient belonging to a large Italian family with ALS first clinically described in 1968. In the family the clinical presentation was characterized by relatively early age of onset, spinal onset with proximal distribution weakness, bulbar involvement and a rapid disease course. Molecular analysis showed a heterozygous mutation at codon 106 resulting in a substitution of phenylalanine for leucine in the SOD1 protein (L106F). In analogy with the previously reported L106V mutation, we propose that the L106F causes a relevant destabilization of the protein chain around the mutation site, able to affect the SOD1 monomer and dimer structures suggesting a pathogenic role for this novel mutation.

Original languageEnglish
Pages (from-to)112-115
Number of pages4
JournalJournal of the Neurological Sciences
Volume293
Issue number1-2
DOIs
Publication statusPublished - Jun 15 2010

Fingerprint

Exons
Mutation
Amyotrophic Lateral Sclerosis
Genes
Phenylalanine
Age of Onset
Codon
Leucine
Neurodegenerative Diseases
Superoxide Dismutase-1
Amyotrophic lateral sclerosis 1
Proteins
History

Keywords

  • Amyotrophic Lateral Sclerosis
  • Familial ALS
  • Mutation
  • Protein structural modelling
  • Superoxide dismutase 1 (SOD1) gene

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Severe familial ALS with a novel exon 4 mutation (L106F) in the SOD1 gene. / Battistini, Stefania; Ricci, Claudia; Lotti, Enrico Maria; Benigni, Michele; Gagliardi, Stella; Zucco, Riccardo; Bondavalli, Massimo; Marcello, Norina; Ceroni, Mauro; Cereda, Cristina.

In: Journal of the Neurological Sciences, Vol. 293, No. 1-2, 15.06.2010, p. 112-115.

Research output: Contribution to journalArticle

Battistini, S, Ricci, C, Lotti, EM, Benigni, M, Gagliardi, S, Zucco, R, Bondavalli, M, Marcello, N, Ceroni, M & Cereda, C 2010, 'Severe familial ALS with a novel exon 4 mutation (L106F) in the SOD1 gene', Journal of the Neurological Sciences, vol. 293, no. 1-2, pp. 112-115. https://doi.org/10.1016/j.jns.2010.03.009
Battistini, Stefania ; Ricci, Claudia ; Lotti, Enrico Maria ; Benigni, Michele ; Gagliardi, Stella ; Zucco, Riccardo ; Bondavalli, Massimo ; Marcello, Norina ; Ceroni, Mauro ; Cereda, Cristina. / Severe familial ALS with a novel exon 4 mutation (L106F) in the SOD1 gene. In: Journal of the Neurological Sciences. 2010 ; Vol. 293, No. 1-2. pp. 112-115.
@article{93dd2bf8a5064dc79b6a31ccddfd0660,
title = "Severe familial ALS with a novel exon 4 mutation (L106F) in the SOD1 gene",
abstract = "Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease associated with a positive familial history in 5-10{\%} of ALS cases. Mutations in the superoxide dismutase-1 (SOD1) gene have been found in 12{\%}-23{\%} of patients diagnosed with familial ALS. Here we report a novel mutation in exon 4 of SOD1 gene in a 55-year-old ALS patient belonging to a large Italian family with ALS first clinically described in 1968. In the family the clinical presentation was characterized by relatively early age of onset, spinal onset with proximal distribution weakness, bulbar involvement and a rapid disease course. Molecular analysis showed a heterozygous mutation at codon 106 resulting in a substitution of phenylalanine for leucine in the SOD1 protein (L106F). In analogy with the previously reported L106V mutation, we propose that the L106F causes a relevant destabilization of the protein chain around the mutation site, able to affect the SOD1 monomer and dimer structures suggesting a pathogenic role for this novel mutation.",
keywords = "Amyotrophic Lateral Sclerosis, Familial ALS, Mutation, Protein structural modelling, Superoxide dismutase 1 (SOD1) gene",
author = "Stefania Battistini and Claudia Ricci and Lotti, {Enrico Maria} and Michele Benigni and Stella Gagliardi and Riccardo Zucco and Massimo Bondavalli and Norina Marcello and Mauro Ceroni and Cristina Cereda",
year = "2010",
month = "6",
day = "15",
doi = "10.1016/j.jns.2010.03.009",
language = "English",
volume = "293",
pages = "112--115",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Severe familial ALS with a novel exon 4 mutation (L106F) in the SOD1 gene

AU - Battistini, Stefania

AU - Ricci, Claudia

AU - Lotti, Enrico Maria

AU - Benigni, Michele

AU - Gagliardi, Stella

AU - Zucco, Riccardo

AU - Bondavalli, Massimo

AU - Marcello, Norina

AU - Ceroni, Mauro

AU - Cereda, Cristina

PY - 2010/6/15

Y1 - 2010/6/15

N2 - Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease associated with a positive familial history in 5-10% of ALS cases. Mutations in the superoxide dismutase-1 (SOD1) gene have been found in 12%-23% of patients diagnosed with familial ALS. Here we report a novel mutation in exon 4 of SOD1 gene in a 55-year-old ALS patient belonging to a large Italian family with ALS first clinically described in 1968. In the family the clinical presentation was characterized by relatively early age of onset, spinal onset with proximal distribution weakness, bulbar involvement and a rapid disease course. Molecular analysis showed a heterozygous mutation at codon 106 resulting in a substitution of phenylalanine for leucine in the SOD1 protein (L106F). In analogy with the previously reported L106V mutation, we propose that the L106F causes a relevant destabilization of the protein chain around the mutation site, able to affect the SOD1 monomer and dimer structures suggesting a pathogenic role for this novel mutation.

AB - Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease associated with a positive familial history in 5-10% of ALS cases. Mutations in the superoxide dismutase-1 (SOD1) gene have been found in 12%-23% of patients diagnosed with familial ALS. Here we report a novel mutation in exon 4 of SOD1 gene in a 55-year-old ALS patient belonging to a large Italian family with ALS first clinically described in 1968. In the family the clinical presentation was characterized by relatively early age of onset, spinal onset with proximal distribution weakness, bulbar involvement and a rapid disease course. Molecular analysis showed a heterozygous mutation at codon 106 resulting in a substitution of phenylalanine for leucine in the SOD1 protein (L106F). In analogy with the previously reported L106V mutation, we propose that the L106F causes a relevant destabilization of the protein chain around the mutation site, able to affect the SOD1 monomer and dimer structures suggesting a pathogenic role for this novel mutation.

KW - Amyotrophic Lateral Sclerosis

KW - Familial ALS

KW - Mutation

KW - Protein structural modelling

KW - Superoxide dismutase 1 (SOD1) gene

UR - http://www.scopus.com/inward/record.url?scp=77952108930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952108930&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2010.03.009

DO - 10.1016/j.jns.2010.03.009

M3 - Article

VL - 293

SP - 112

EP - 115

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -